Skip to content

NRC Health

NRC· NasdaqCore metricsCIK 70487

Commercial physical & biological research16 peers

Last sale
Nov 12, 2026 · -0.47%
Market cap
$566.40M
21.22M shares
Filings
1,010
$38.40M
Q3 2026−4.0% FY25 yoy
$4.70M
Q3 2026−53.2% FY25 yoy
$8.91M
Q3 2026−35.8% FY25 yoy
$12.39M
Q3 2026derived−17.9% FY25 yoy
$0.21
Q3 2026+4,707.7% FY25 yoy
$3.63M
Q3 2026−2.2% FY25 yoy
$566.40M
88.0×
3.9×
—
3.26%
2.38%

Twelve months to Sep 30, 2026 · derived

Price

$26.69+78.65%+$11.75past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$137.39MFY 2025
$151.57M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$137,390,000reported
FY 20242024-12-31$143,060,000reported
FY 20232023-12-31$148,580,000reported
FY 20222022-12-31$151,568,000reported
FY 20212021-12-31$147,954,000reported
FY 20202020-12-31$133,277,000reported
FY 20192019-12-31$127,982,000reported
FY 20182018-12-31$119,686,000reported
FY 20172017-12-31$117,559,000reported
FY 20162016-12-31$109,384,000reported
FY 20152015-12-31$102,343,000reported
FY 20142014-12-31$98,837,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$10.98M$20.18M$31.16M$0.5222.54M sh−1.8%197.9%
FY2024$11.45M$30.95M$42.40M$0.4822.95M sh−3.8%221.1%
FY2023$36.37M$19.10M$55.47M$1.4823.85M sh−3.0%248.3%
FY2022$20.96M$27.62M$48.58M$0.8424.59M sh−2.4%183.8%
FY2021$9.16M$4.14M$13.30M$0.4825.19M sh−1.0%32.6%

Segments

Geography
Revenue by Geography, FY2018 to FY2024FY2018UNITED STATES · FY2018 · $115.45MCANADA · FY2018 · $4.24MFY2019UNITED STATES · FY2019 · $124.37MCANADA · FY2019 · $3.61MFY2020UNITED STATES · FY2020 · $130.31MCANADA · FY2020 · $2.97MFY2021UNITED STATES · FY2021 · $144.99MCANADA · FY2021 · $2.97MFY2022UNITED STATES · FY2022 · $150.78MCANADA · FY2022 · $793.00KFY2023UNITED STATES · FY2023 · $148.58MFY2024UNITED STATES · FY2024 · $143.06M
LineFY2024ShareChange
UNITED STATES$143.06M100%−3.7%
CANADA$0.00——
Total$143.06M

From the 10-K filed Mar 17, 2025NRC

Commercial physical & biological research

NRC Health is the 6th largest of the 17 covered companies the SEC files under this code, by revenue. SIC 8731

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

NRC Health · CIK 70487 · Engraved from SEC EDGAR